Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Andrew Liss"'
Autor:
Geoffrey Brown, Andrew Liss
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 12 (2024)
Externí odkaz:
https://doaj.org/article/98d33ba530744ba9b76cce2daf3aefe8
Autor:
Koetsu Inoue, Daniel H. Schanne, Aya Matsui, Pinji Lei, Sebastian Klein, Shuichi Aoki, Hajime Taniguchi, Hiroto Kikuchi, Jiang Chen, Zelong Liu, Shengdar Q. Tsai, Tyge CE Schmidt, Masaaki Iwasaki, Glenn Geidel, Alexander Koch, Peigen Huang, Dai Fukumura, Toshihiro Shioda, Lance L. Munn, Carlos Fernandez-del Castillo, Theodore S. Hong, Rakesh K. Jain, Andrew Liss, Nabeel Bardeesy, Dan G. Duda
Activating mutations of KRAS play critical roles in the initiation and progression of pancreatic ductal adenocarcinoma (PDAC). Accumulating evidence indicates that distinct KRAS alleles associate with different prognoses, but the underlying mechanism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::667e9627883e7ffeeaf8fb819b5bcd5f
https://doi.org/10.1101/2022.06.29.497540
https://doi.org/10.1101/2022.06.29.497540
Publikováno v:
Cancer Research. 83:876-876
Here, we describe analyses towards the first tumor/normal benchmark from the Genome in a Bottle (GIAB) consortium using new cell lines from a broadly-consented pancreatic ductal adenocarcinoma patient. This effort builds on the widely-used germline v
Autor:
Colin D. Weekes, David Tsai Ting, Aparna Raj Parikh, Stacie Ittershagen, Claire Fabre, Viviana Cremasco, David Ruddy, Andrew Liss, Aileen O'Shea, Mukesh Harisinghani, Michelle Piquet, Jonathan Chang, Eunice Lee Kwak, David P. Ryan
Publikováno v:
Journal of Clinical Oncology. 41:TPS762-TPS762
TPS762 Background: Overcoming resistance to chemotherapy and immune checkpoint inhibitors remains an unmet need for PDAC. In this context, TGF-β plays a key role in PDAC by promoting the activation of fibroblasts and extracellular matrix deposition,
Autor:
William L. Hwang, Karthik Jagadeesh, Jimmy Guo, Hannah I. Hoffman, Payman Yadollahpour, Jason Reeves, Prajan Divakar, Toni Delorey, Arnav Mehta, Jaimie Lynn Barth, Piotr Zelga, Theodore S. Hong, Rakesh K. Jain, Andrew Aguirre, Carlos Fernandez Del-Castillo, Mari Mino-Kenudson, Andrew Liss, David Tsai Ting, Aviv Regev, Tyler Jacks
Publikováno v:
Journal of Clinical Oncology. 40:610-610
610 Background: Pancreatic ductal adenocarcinoma (PDAC) is highly lethal and resistance to chemotherapy and radiotherapy is a major obstacle to improving clinical outcomes. Hence, there is an urgent need to elucidate the gene expression programs, spa
Autor:
Kim Barroso, Olivier Binda, Maria Victoria Botuyan, Anna L. Chambers, Eric Chevet, Jocelyn Côté, Florence Couteau, Jean-François Couture, Jessica A. Downs, Joel C. Eissenberg, Maite G. Fernandez-Barrena, Martin Ernesto Fernandez-Zapico, Raquel Fueyo, María Alejandra García, Alexandre Gaspar-Maia, John Haddad, Nasim Haghandish, Elisabeth Hessmann, Jonathan M.G. Higgins, Ryan A. Hlady, Timothy C. Humphrey, Steven A. Johnsen, Alexander Koenig, María Julia Lamberti, Sylvain Lanouette, Andrew Liss, Gwen A. Lomberk, Frédérick A. Mallette, Sridhar Mani, Marian A. Martínez-Balbás, Georges Mer, Emma A. Morrison, Catherine A. Musselman, Sankari Nagarajan, Christopher L. Pin, Keith D. Robertson, Andrea Ropolo, María Roqué, Natalia Belén Rumie Vittar, Güenter Schneider, Ana Sevilla, Steven G. Smith, Maria Carolina Touz, Raul Urrutia, Laura Vargas-Roig, Renzo Emanuel Vera, Nikolaus A. Watson, Xiang-Jiao Yang, Pamela Zhang, Ming-Ming Zhou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6266738ca1055879469c712948b274e6
https://doi.org/10.1016/b978-0-12-802389-1.01002-9
https://doi.org/10.1016/b978-0-12-802389-1.01002-9